Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01
Published September 26, 2018 · Recall initiated: August 23, 2018
Summary
FDA records drug Class III recall D-1214-2018, published September 26, 2018 and initiated August 23, 2018. Recalling firm: LUPIN SOMERSET; Status: Terminated; Reported quantity: 4716 bottle; Lot: Lot# S800232, Exp 2/20. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if MORPHINE SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MORPHINE SULFATE
- Manufacturer
- LUPIN SOMERSET
- Distributor
- U.S.A. Nationwide
- UPC
- 0343386542017
- Lot
- Lot# S800232, Exp 2/20
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMorphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular orAugust 26, 2026
- FDAMorphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, ManufacturedDecember 17, 2025
- FDAMorphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: OhmMarch 12, 2025
- FDAMorphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, ILOctober 6, 2021
- FDAMethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc.September 26, 2018
- FDACedarLane Organic Salads; Couscous, Veggies & Chickpeas with Citrus Dressing. NET WT 9 oz. -Gluten FreeSeptember 26, 2018
Questions about this recall
Was Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01 recalled?
Yes. FDA published recall D-1214-2018 on September 26, 2018. Reported hazard: Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MORPHINE SULFATE. UPC: 0343386542017.